虹膜素通过抑制脂肪细胞中通过TLR4/MyD88/NF-κB轴的干扰来缓解因肥胖引起的骨质损失
Yuanshu Zhang1, Xu He2, Kai Wang1
1Department of Orthopedics, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu 214026, PR China; Department of Orthopedics, The First Affiliated Hospital of Soochow University, Orthopedics Institute of Soochow University, Suzhou, Jiangsu 215006, PR China.
Journal of advanced research
|April 16, 2024
概括
一种肌素的虹膜素通过抑制脂肪细胞分化和通过TLR4/MyD88/NF-κB通路减少互白素-6 (IL-6) 来缓解肥胖引起的骨质损失,从而增强骨形成.
科学领域:
- 内分泌学和新陈代谢学
- 骨生物学和骨质疏松症研究研究
- 脂肪细胞生物学和信号传递
背景情况:
- 肥胖是一个全球性的健康问题,与骨质降低和骨质疏松症有关.
- 素,一种由纤维素第3类域含蛋白5 (FNDC5) 衍生出来的肌素,影响骨和脂肪代谢.
- 素在骨髓微环境中调解肥胖对骨代谢的影响中的作用需要阐明.
研究的目的:
- 通过研究虹膜素对骨代谢的影响,特别是通过其对脂肪细胞的影响.
- 在肥胖的背景下,探索虹膜素影响骨髓中介质干细胞 (BMSCs) 差异化的机制.
主要方法:
- 使用的纤维素第3类域含蛋白5 (FNDC5) 淘汰赛小鼠接受高脂肪饮食 (HFD),并通过微型CT和组织学评估骨质量.
- 试验室研究涉及评估骨髓介质干细胞 (BMSCs) 的脂原和骨原分化.
- 使用RNA测序和确认的信号通路 (TLR4/MyD88/NF-κB) 分析了差异化脂肪细胞中的基因表达,并采用了西斑和qRT-PCR.
主要成果:
- 与标准饮食对照相比,高脂肪饮食养的FNDC5淘汰赛小鼠表现出体重增加,骨髓脂肪增加和骨形成减少.
- 在体外,虹膜素抑制了BMSC分化成脂肪细胞,并挽救了由脂肪细胞超位抑制的骨质生成.
- 虹膜素通过TLR4/MyD88/NF-κB通路降低脂肪细胞中介素-6 (IL-6) 的产生,在HFD养的FNDC5淘汰赛小鼠中观察到IL-6的增加.
结论:
- 虹膜素通过降低TLR4/MyD88/NF-κB通路的调节和减少脂肪细胞中IL-6的产生来增强BMSC的骨质生成.
- 准伊丽素对脂肪细胞衍生的IL-6的调节,为肥胖引起的骨质疏松症提供了潜在的治疗策略.
- 这项研究强调了虹膜素对高脂肪饮食引起的骨质损失的保护作用.
关键词:
脂肪细胞是一种脂肪细胞.在IL-6的研究中,IL-6被认为是IL-6的基因.虹膜 虹膜是一种虹膜.骨质发生过程 (osteogenesis)TLR4 / MyD88 / NF-κBB / TLR4 / MyD88 / NF-κBB / TLR4 / MyD88 / MyD88 / NF-κBB / TLR4 / MyD88 / MyD88 / MyD88 / TLR4 / MyD88 / MyD88 / TLR4 / MyD88 / MyD88 / MyD88 / MyD88 / TLR4 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 /相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


